FAIR_I_Report_December2020.pdf (2MB)
JPAC Position Statement on vCJD - September 2024.pdf (240KB)
JPAC Position Statement on Dengue Virus - September 2024.pdf (128KB)
JPAC Position Statement on Residual Risk - September 2024.pdf (110KB)
CN 46-2024 - COVID-19 vaccination v1.pdf (287KB)
CN 51-2024 - Migraine and Topiramate v1.pdf (223KB)
CN 49-2024 - Monoclonal Antibody Therapies v1.pdf (263KB)
CN 48-2024 - Haemolytic Anaemia v1.pdf (237KB)
CN 47-2024 - Topical Anti-Androgens v1.pdf (174KB)
CN 45-2024 - Hepatitis A v1.pdf (299KB)